Pain management is an important aspect of nursing care.
Pain is a common reason for seeking healthcare.
Pain can lead to suffering and economic burden.
Pain
Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage.
It's a personal and individual experience.
Pain is whatever the patient says it is and exists when the patient says it exists.
Pain involves physical, psychological, and cultural factors.
The Patient Experiencing Pain
Culture influences beliefs, thoughts, and ways of managing pain.
Attitudes, meanings, and perceptions of pain vary with culture, race, and ethnicity.
African Americans may believe in healers who use religious faith, prayer, and laying on of hands.
Hispanic Americans may use prayer, amulets, herbs, and spices.
Chinese traditional methods include acupuncture, herbal remedies, yin and yang balancing, and cold treatment (moxibustion).
Asian and Pacific Islander patients may be reluctant to express pain, believing it's God's will or punishment.
Native Americans may use massage, heat, sweat baths, herbal remedies, and harmony with nature.
In Arab culture, patients may openly express pain and expect immediate relief through injections or intravenous drugs.
Awareness of cultural influences is important for effective and individualized nursing care.
Pain Management Approach
No single approach is effective for all patients.
Tailored to each patient's needs considering:
Cause of pain
Concurrent medical conditions
Characteristics of pain
Psychological and cultural characteristics
Requires ongoing reassessment of pain and treatment effectiveness.
Classification of Pain by Onset and Duration
Acute pain:
Sudden onset
Usually subsides once treated
Chronic pain:
Persistent or recurring
Often difficult to treat
Tolerance
Physical dependence
Length beyond 3 months
Classification of Pain
Somatic
Visceral
Superficial
Deep
Vascular
Referred
Neuropathic
Phantom
Cancer
Central
Key Concepts (Definitions)
Chronic pain: Persistent or recurring pain lasting longer than 3-6 months, or 1 month after acute injury healing, or with non-healing tissue injury.
Deep pain: Pain in tissues below skin level, opposite of superficial pain.
Gate theory: Explains pain transmission and relief using a gate model.
Narcotics: Legal term for drugs producing insensibility or stupor, especially opioids (but term is falling out of use).
Neuropathic pain: Pain from a disturbance of nerve function.
Nociception: Processing of pain signals in the brain.
Nociceptors: Sensory nerves (A and C fibers) transmitting pain signals to the CNS.
Nonopioid analgesics: Analgesics not classified as opioids.
Pain threshold: The level of a stimulus that results in the sensation of pain.
Pain tolerance: The amount of pain a patient can endure without it interfering with normal function.
Partial agonist: Drug that binds to a receptor and causes a response that is less than that caused by a full agonist (same as agonist-antagonist).
Phantom pain: Pain experienced in an amputated body part.
Physical dependence: Unpleasant physical symptoms (withdrawal) occur if a drug is stopped abruptly.
Psychologic dependence: Compulsive use of opioids or other addictive substance characterized by a continuous craving for the substance and the need to use it for effects other than pain relief (also called addiction).
Referred pain: Pain occurring in an area away from the organ of origin.
Somatic pain: Pain originating from skeletal muscles, ligaments, or joints.
Acute pain: Pain that is sudden in onset, usually subsides when treated, and typically occurs over less than a 6-week period.
Addiction: A chronic, neurobiologic disease whose development is influenced by genetic, psychosocial, and environmental factors (same as psychologic dependence).
Adjuvant analgesic drugs: Drugs that are added for combined therapy with a primary drug and may have additive or independent analgesic properties, or both.
Agonist: A substance that binds to a receptor and causes a response.
Agonists-antagonists: Substances that bind to a receptor and cause a partial response that is not as strong as that caused by an agonist (also known as a partial agonist).
Analgesic ceiling effect: Occurs when a given pain drug no longer effectively controls pain despite the administration of the highest safe dosages.
Analgesics: Medications that relieve pain without causing loss of consciousness (sometimes referred to as painkillers).
Antagonist: A drug that binds to a receptor and prevents (blocks) a response.
Breakthrough pain: Pain that occurs between doses of pain medication.
Cancer pain: Pain resulting from any of a variety of causes related to cancer and/or the metastasis of cancer.
Central pain: Pain resulting from any disorder that causes central nervous system damage.
Nonsteroidal antiinflammatory drugs (NSAIDS): A large, chemically diverse group of drugs that are analgesics and also possess antiinflammatory and antipyretic activity.
Opioid analgesics: Synthetic drugs that bind to opiate receptors to relieve pain.
Opioid naive: Describes patients who are receiving opioid analgesics for the first time and who therefore are not accustomed to their effects.
Opioid tolerance: A normal physiologic condition that results from long-term opioid use, in which larger doses of opioids are required to maintain the same level of analgesia and in which abrupt discontinuation of the drug results in withdrawal symptoms (same as physical dependence).
Opioid tolerant: The opposite of opioid naïve; describes patients who have been receiving opioid analgesics (legally or otherwise) for a period of time (1 week or longer).
Opioid withdrawal: The signs and symptoms associated with abstinence from or withdrawal of an opioid analgesic when the body has become physically dependent on the substance.
Opioids: A class of drugs used to treat pain. This term is often used interchangeably with the term narcotic.
Pain: An unpleasant sensory and emotional experience associated with actual or potential tissue damage.
Special pain situations: The general term for pain control situations that are complex and whose treatment typically involves multiple medications, and nonpharmacologic therapeutic modalities (e.g., massage, chiropractic care, surgery).
Superficial pain: Pain that originates from the skin or mucous membranes; opposite of deep pain.
Synergistic effects: Drug interactions in which the effect of a combination of two or more drugs with similar actions is
greater than the sum of the individual effects of the same drugs given alone. For example, 1+1 is greater than 2.
Tolerance: The general term for a state in which repetitive exposure to a given drug, over time, induces changes in drug
receptors that reduce the drug's effects (same as physical dependence).
Vascular pain: Pain that results from pathology of the vascular or perivascular tissues.
Visceral pain: Pain that originates from organs or smooth muscles.
World Health Organization (WHO): An international body of
health care professionals that studies and responds to health needs and trends worldwide.
Analgesics
Medications that relieve pain without causing loss of consciousness
"Painkillers"
Opioid analgesics
Adjuvant analgesic drugs
Adjuvant Drugs
Assist primary drugs in relieving pain
Examples:
NSAIDs
Antidepressants
Anticonvulsants
Corticosteroids
Example: adjuvant drugs for neuropathic pain
Amitriptyline (antidepressant)
Gabapentin or pregabalin (anticonvulsants)
Opioid Drugs
Synthetic drugs that bind to opiate receptors to relieve pain
Mild agonists: codeine, hydrocodone
Strong agonists: morphine, hydromorphone, oxycodone, meperidine, fentanyl, and methadone
Meperidine: not recommended for long-term use because of the accumulation of a neurotoxic metabolite, normeperidine, which can cause seizures
World Health Organization Three-Step Analgesic Ladder
Step 1: nonopioids (with or without adjuvant medications) after the pain has been identified and assessed. If pain persists or increases, treatment moves to
Step 2: opioids with or without nonopioids and with or without adjuvants. If pain persists or increases, management then rises to
Step 3: opioids indicated for moderate to severe pain, administered with or without nonopioids or adjuvant medications.
Opioid Analgesics: Mechanism of Action
Three classifications based on their actions
Agonists
Agonists-antagonists
Antagonists (nonanalgesic)
Opioid Analgesics: Indications
Main use: to alleviate moderate to severe pain
Often given with adjuvant analgesic drugs to assist primary drugs with pain relief
Opioids are also used for:
Cough center suppression
Treatment of diarrhea
Balanced anesthesia
Opioid Analgesics: Contraindications
Known drug allergy
Severe asthma
Use with extreme caution in patients with:
Respiratory insufficiency
Elevated intracranial pressure
Morbid obesity or sleep apnea
Paralytic ileus
Pregnancy
Opioid Analgesics: Adverse Effects
CNS depression
Leads to respiratory depression (most serious adverse effect)
Nausea and vomiting
Urinary retention
Diaphoresis and flushing
Pupil constriction (miosis)
Constipation
Itching
Opioids: Opioid Tolerance
A common physiologic result of chronic opioid treatment
Result: larger dose is required to maintain the same level of analgesia
Opioids: Physical Dependence
Physiologic adaptation of the body to the presence of an opioid
Opioid tolerance and physical dependence are expected with long-term opioid treatment and should not be confused with psychologic dependence (addiction).
Opioids: Psychologic Dependence
A pattern of compulsive drug use characterized by a continued craving for an opioid and the need to use the opioid for effects other than pain relief
Opioid Analgesics: Toxicity and Management of Overdose
Naloxone (Narcan)
Naltrexone (ReVia)
Regardless of withdrawal symptoms, when a patient experiences severe respiratory depression, an opioid antagonist should be given.
Opioid Analgesics: Interactions
Alcohol
Antihistamines
Barbiturates
Benzodiazepines
Monoamine oxidase inhibitors
Others
Codeine Sulfate
Opioid agonist
Natural opiate alkaloid (Schedule II) obtained from opium
Less effective; ceiling effect
Often combined with acetaminophen (Schedule III)
More commonly used as an antitussive drug
Most common adverse effect: GI disturbance
Fentanyl
Synthetic opioid (Schedule II) used to treat moderate to severe pain
Forms: Parenteral injections, transdermal patches (Duragesic), buccal lozenges (Fentora), buccal lozenges on a stick (Actiq)
0.1 mg IV fentanyl = 10 mg IV morphine
Fentanyl patch for chronic, long-term pain management
Hydromorphone (Dilaudid)
Very potent opioid analgesic; Schedule II drug
1 mg IV/IM hydromorphone = 7 mg morphine
Exalgo:
Osmotic extended-release oral delivery
Difficult to crush/extract for injection (reducing abuse potential)
Meperidine
Synthetic opioid analgesic (Schedule II)
Use with caution in elderly or those with kidney dysfunction
Active metabolite (normeperidine) can accumulate to toxic levels, causing seizures
Rarely used; not recommended for long-term pain treatment
Uses: Migraine treatment, post-op shivering
Morphine Sulfate
Naturally occurring alkaloid derived from the opium poppy
Drug prototype for all opioid drugs; Schedule II controlled substance
Indication: severe pain
High abuse potential
Dosage forms: oral, injectable, rectal; also extended-release
Tramadol Hydrochloride
Trade name: Ultram
Centrally acting analgesic with a dual mechanism of action
Weak bond to mu opioid receptors
Inhibits the reuptake of norepinephrine and serotonin
Indicated for moderate to moderately severe pain
Adverse effects similar to those of opioids
Careful use in patients taking SSRIs, MAOIs, neuroleptics
Oxycodone hydrochloride
Analgesic agent structurally related to morphine (Class II)
Comparable analgesic activity to morphine
Often combined with acetaminophen (Percocet) or with aspirin (Percodan)
IR = immediate release
SR = sustained release
Hydrocodone (weaker) often combined with acetaminophen (Vicodin, Norco)
Naloxone Hydrochloride (Narcan)
Pure opioid antagonist
Drug of choice for complete/partial reversal of opioid-induced respiratory depression
Indicated in cases of suspected acute opioid overdose
Failure to reverse presumed opioid overdose suggests condition may not be related to opioids
Opioid Antagonists
Naloxone now available without a prescription; used by first responders for opioid/illegal drug overdoses
Naltrexone
Opioid antagonist (oral form)
Used for alcohol and opioid addiction
Nonopioid Analgesics: Acetaminophen (Tylenol)
Analgesic and antipyretic effects
Little to no anti-inflammatory effects
Available over-the-counter (OTC) and in combination products with opioids
Acetaminophen: Mechanism of Action
Similar to salicylates
Blocks pain impulses peripherally by inhibiting prostaglandin synthesis
Acetaminophen: Indications
Mild to moderate pain, fever
Alternative for those who cannot take aspirin products
Acetaminophen: Dosage
Maximum daily dose for healthy adults is being lowered to 3000 mg/day
2000 mg for older adults and those with liver disease
Inadvertent excessive doses may occur when different combination drug products are taken together
Be aware of the acetaminophen content of all medications taken by the patient (OTC and prescription).
Acetaminophen: Contraindications and Interactions
Should not be taken in the presence of:
Drug allergy
Liver dysfunction / possible liver failure
G6PD deficiency
Dangerous interactions with alcohol or other hepatotoxic drugs
Lidocaine, transdermal
Topical anesthetic
Indications: postherpetic neuralgia
Left in place no longer than 12 hours
Minimal adverse effects; skin irritation may occur
Analgesics: Nursing Process: Assessment
Thorough history regarding allergies and use of other medications, including alcohol, health history, and medical history.
Obtain baseline vital signs and I&O.
Assess for potential contraindications and drug interactions.
Do not cause hypotension and respiratory depression unless taken with other CNS depressants
Treatment symptomatic and supportive
Flumazenil as an antidote
Benzodiazepines: Interactions
Azole antifungals, verapamil, diltiazem, protease inhibitors, macrolide antibiotics, grapefruit juice
CNS depressants (alcohol, opioids)
Olanzapine
Rifampin
Herbal Interactions
Food-drug Interactions
Opioids
Diazepam (Valium)
First clinically available benzodiazepine drug. It has varied uses
Treatment of anxiety
Procedural sedation and anesthesia adjunct
Anticonvulsant therapy
Skeletal muscle relaxation
Available in multiple forms:
Oral
Rectal
Injectable
Midazolam (Versed)
Used preoperatively and for moderate sedation
Causes amnesia and anxiolysis (reduced anxiety) as well as sedation
Normally administered by injection in adults
Liquid oral dosage form is also available for children.
High-alert medication
Temazepam (Restoril)
Intermediate-acting benzodiazepine
One of the metabolites of diazepam
Normally induces sleep within 20 to 40 minutes
Long onset of action, so it is recommended that patients take it about 1 hour prior to going to bed
Still an effective hypnotic; however, it has been replaced by newer drugs
Nonbenzodiazepines Medication: Zolpidem (Ambien)
Enhance the action of gamma-amino butyric acid (GABA) in the CNS.
These medications do not function as antianxiety, muscle relaxant, or antiepileptic agents.
Short half life, rapid onset of action: take immediately going to bed
Food inhibit absorption: empty stomach
There is a low risk of tolerance, abuse, and dependence.
Therapeutic Uses
Management of insomnia
Other Medications:
Buspirone (Buspar)
Trazodone (antidepressant) (Desyrel)
Mirtazapine (antidepressant) (Remeron)
Nonbenzodiazepines Side/Adverse Effects
Daytime sleepiness and lightheadedness. Advise clients to take medication at bedtime, allowing for at least 8 hr of sleep.
Contraindications/Precautions
* Contraindicated in clients who are breastfeeding
* Use cautiously in older adult clients and in clients with impaired kidney, liver, and/or respiratory function.
Medication/Food Interactions
CNS depressants such as alcohol, barbiturates, opioids cause additive CNS depression.
Nonbenzodiazepine: Zolpidem (Ambien)
Short-acting nonbenzodiazepine hypnotic
Lower incidence of daytime sleepiness compared with benzodiazepine hypnotics
Ambien CR is a longer acting form with two separate drug reservoirs.
Concerns about somnambulation (sleep-walking)
Nonbenzodiazepine: Eszopiclone (Lunesta)
First hypnotic to be FDA approved for long-term use
Designed to provide a full 8 hours of sleep
Considered a short- to intermediate-acting agent
Patients should allot 8 hours of sleep time and should avoid taking hypnotics when they must awaken in less than 6 to 8 hours.
Nonbenzodiazepine: Ramelteon (Rozerem)
Structurally similar to the hormone melatonin: works as an agonist at melatonin receptors in the CNS
Technically, it is not a CNS depressant; used as hypnotic
Not classified as a controlled substance
Indicated for patients who have difficulty with sleep onset rather than sleep maintenance
Herbal Products: Kava
Used to relieve anxiety, stress, and restlessness and to promote sleep